The global metabolic testing market is gaining momentum as rising cases of lifestyle diseases and the demand for personalized healthcare drive adoption. With innovations in non-invasive technologies and government-backed initiatives, the market is set for strong growth over the next decade.
The metabolic testing market was valued at USD 547.32 million in 2024 and is projected to grow from USD 589.03 million in 2025 to USD 1,060.82 million by 2033, expanding at a CAGR of 7.63% during the forecast period.
Metabolic testing plays a critical role in assessing how the body processes nutrients, burns calories, and responds to physical activity. These tests are used in diagnosing conditions like obesity, diabetes, and thyroid disorders while also supporting fitness, nutrition planning, and preventive healthcare. With increasing awareness of metabolic health, the market is experiencing strong adoption in hospitals, laboratories, and even sports performance centers.
Market Drivers and Opportunities
The rise in lifestyle diseases such as obesity, diabetes, and cardiovascular conditions is one of the major factors fueling demand. According to the World Obesity Atlas 2022, over 1 billion people worldwide could be living with obesity by 2030, while the International Diabetes Federation reports 400 million+ adults already affected by diabetes. These figures highlight the urgent need for advanced diagnostic and monitoring solutions.
However, the high costs of metabolic testing equipment, ranging from USD 150,000 to 300,000 for setup and USD 45,000 annually for maintenance, remain a challenge, particularly for smaller facilities. Despite this, breakthroughs in non-invasive testing technologies and government-backed research funding are creating promising opportunities. For example, MOGLU by Apollon, a non-invasive glucose monitoring device, showcased at CES 2025, is expected to transform real-time metabolic health assessments.
Regional Insights
-
North America dominates the market, led by the U.S., thanks to advanced healthcare infrastructure, high obesity prevalence, and major players like LabCorp, Abbott, and Medtronic.
-
Asia-Pacific is emerging as the fastest-growing region, with rising obesity and diabetes rates in China and India and expanding healthcare access across the region.
-
Europe sees strong adoption in countries like Germany, supported by advanced healthcare systems and preventive care focus.
-
Japan and South Korea leverage cutting-edge technology and an aging population to drive adoption, while South Africa is experiencing steady demand due to rising chronic diseases.
Segmentation Highlights
-
By Technology: VO2 Max analysis leads, widely used in clinical diagnostics, sports, and fitness performance monitoring.
-
By Applications: Metabolic disorders dominate due to increasing global cases of diabetes and obesity.
-
By Product: Metabolic carts hold the largest share, offering accurate diagnostic capabilities.
-
By End-User: Hospitals remain the top adopters, driven by rising demand for accurate metabolic diagnostics.
Key Players
-
Parvo Medics
-
AEI Technologies, Inc.
-
Microlife Medical Home Solutions, Inc.
-
KORR Medical Technologies, Inc.
-
General Electric Company
-
OSI Systems, Inc.
-
Geratherm Medical AG
-
MGC Diagnostic Corporation
-
CORTEX Biophysik GmbH
-
COSMED
-
CareFusion Corporation
Recent Developments
In February 2025, ENDRA Life Sciences installed its first TAEUS liver system at King's College Hospital NHS Foundation Trust in London. The clinical study aims to compare its liver fat assessment accuracy with MRI standards, marking a step forward in non-invasive metabolic disease detection.
Analyst View
Experts believe the market will continue expanding as healthcare providers, sports organizations, and patients seek more precise, cost-effective, and personalized metabolic health solutions. While high costs and lack of standardization remain challenges, technological innovations and increased investments are expected to fuel significant adoption over the next decade.
About Us:
Straits Research is a leading global market intelligence and consulting firm, dedicated to delivering actionable insights and in-depth analysis across a wide range of industries. Our mission is to empower organizations, investors, and decision-makers with reliable data, strategic guidance, and forward-looking perspectives to help them thrive in a rapidly evolving business landscape.
Contact Us:
Email: sales@straitsresearch.com
Tel: +1 646 905 0080 (U.S.), +44 203 695 0070 (U.K.)
Website: https://straitsresearch.com/